Industry / Pakistan
Drugmakers Call For Higher Prices
May 2008 | Industry NewsDue to erosion of margins, pharmaceutical companies have called on Pakistan's government to allow them to increase the price of medicines. The firms say that the price of drugs has remained stable for the last five years, while the cost of production has risen by one-fifth over the same period. It is BMI's view that the price controls will remain in place for the medium term, primarily because of the widespread
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.



